Kwang Dong Pharmaceutical Overview

  • Year Founded
  • 1963

Year Founded

  • Status
  • Public

  • Employees
  • 1,049

Employees

  • Stock Symbol
  • 009290

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $4.70
  • (As of Friday Closing)

Kwang Dong Pharmaceutical General Information

Description

Kwang Dong Pharmaceutical Co Ltd is a drug store company. It manufactures and markets medicines and health-aids foods. The company originally focuses on the oriental medicine based drugs but succeeds in health aid beverages. Kwang's products include Vitamins, Antipyretic, Analgesic, Eye drops and amongst others.

Contact Information

Website
www.ekdp.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Gasan Building, 85
  • Seochojungang-ro, Seocho
  • Seoul, 11220
  • South Korea
+82
Primary Industry
Beverages
Other Industries
Food Products
Pharmaceuticals
Stock Exchange
KRX
Corporate Office
  • Gasan Building, 85
  • Seochojungang-ro, Seocho
  • Seoul, 11220
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kwang Dong Pharmaceutical Stock Performance

As of 13-Nov-2026, Kwang Dong Pharmaceutical’s stock price is $4.70. Its current market cap is $234M with 49.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.70 $4.74 $3.33 - $8.84 $234M 49.7M 161K $0.35

Kwang Dong Pharmaceutical Financials Summary

As of 30-Jun-2026, Kwang Dong Pharmaceutical has a trailing 12-month revenue of $1.18B.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 300,721 238,941 227,242 218,849
Revenue 1,176,422 1,166,095 1,202,488 1,158,327
EBITDA 41,546 39,549 56,279 49,205
Net Income 15,037 14,734 29,669 28,273
Total Assets 849,251 916,890 794,500 836,566
Total Debt 195,027 210,560 194,112 182,855
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kwang Dong Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kwang Dong Pharmaceutical‘s full profile, request access.

Request a free trial

Kwang Dong Pharmaceutical Patents

Kwang Dong Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024242502-A1 Enzymatic preparation method for 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol Inactive 25-May-2023
WO-2023106777-A1 Vital melon (kctc14699bp) and anti-obesity composition comprising extract thereof Inactive 10-Dec-2021
JP-2015183003-A Male sterility preventive and therapeutic pharmaceutical composition containing mixtures of rehmannia glutinosa liboschitz var.purpurae makino, lycium chinense miller, aquillaria agallocha roxburgh, poria cocos wolf, panax ginseng ca meyer and honey as active ingredients Active 25-Mar-2014
WO-2014163260-A1 Composition for skin whitening containing corn silk extract Inactive 02-Apr-2013
JP-2014011971-A Production method of corn hair tea Active 04-Jul-2012
To view Kwang Dong Pharmaceutical’s complete patent history, request access »

Kwang Dong Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kwang Dong Pharmaceutical Investments & Acquisitions (11)

Kwang Dong Pharmaceutical’s most recent deal was a Secondary Transaction - Private with Precision Biosensor for . The deal was made on 02-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Precision Biosensor 02-Oct-2024 Secondary Transaction - Private Diagnostic Equipment
Issuing Electronic Securities (Finger / Kwangdong Pharmaceutical) 24-Jul-2024 Joint Venture Other Financial Services
Kwangdong Healthbio 02-Jan-2024 Merger/Acquisition Pharmaceuticals
CT Bio 31-Jan-2023 Corporate Monitoring Equipment
Vitrosys 01-Aug-2022 Later Stage VC Drug Discovery
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Kwang Dong Pharmaceutical ESG

Risk Overview

Risk Rating

Updated September, 30, 2025

43.95 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Pharmaceuticals

Subindustry

of 438

Rank

Percentile

To view Kwang Dong Pharmaceutical’s complete esg history, request access »

Kwang Dong Pharmaceutical Exits (4)

Kwang Dong Pharmaceutical’s most recent exit was on 31-Jan-2023 from CT Bio. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
CT Bio 31-Jan-2023 Completed
BM Stage 29-Jun-2022 Completed
  • 3 buyers
QuadMedicine 09-May-2022 Completed
  • 8 buyers
Adolor 01-Nov-1997 Later Stage VC Completed
To view Kwang Dong Pharmaceutical’s complete exits history, request access »

Kwang Dong Pharmaceutical Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Korea ePlatform Seoul, South Korea 2000
KD Investment (Credit Finance)

Kwang Dong Pharmaceutical FAQs

  • When was Kwang Dong Pharmaceutical founded?

    Kwang Dong Pharmaceutical was founded in 1963.

  • Where is Kwang Dong Pharmaceutical headquartered?

    Kwang Dong Pharmaceutical is headquartered in Seoul, South Korea.

  • What is the size of Kwang Dong Pharmaceutical?

    Kwang Dong Pharmaceutical has 1,049 total employees.

  • What industry is Kwang Dong Pharmaceutical in?

    Kwang Dong Pharmaceutical’s primary industry is Beverages.

  • Is Kwang Dong Pharmaceutical a private or public company?

    Kwang Dong Pharmaceutical is a Public company.

  • What is Kwang Dong Pharmaceutical’s stock symbol?

    The ticker symbol for Kwang Dong Pharmaceutical is 009290.

  • What is the current stock price of Kwang Dong Pharmaceutical?

    As of 13-Nov-2026 the stock price of Kwang Dong Pharmaceutical is $4.70.

  • What is the current market cap of Kwang Dong Pharmaceutical?

    The current market capitalization of Kwang Dong Pharmaceutical is $234M.

  • What is Kwang Dong Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Kwang Dong Pharmaceutical is $1.18B.

  • What is Kwang Dong Pharmaceutical’s annual earnings per share (EPS)?

    Kwang Dong Pharmaceutical’s EPS for 12 months was $0.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process